Report ID: SQMIG35B2174
Report ID:
SQMIG35B2174 |
Region:
Global |
Published Date: December, 2024
Pages:
157
|
Tables:
114 |
Figures:
67
North America held the dominant share with an estimated 40.37% share earned in 2022. This is owing to the presence of well-established healthcare infrastructure, coupled with an extensive reimbursement framework. Additionally, the increasing implementation of novel diagnostics, and adoption of healthcare insurance policies will further help this region continue dominance. Furthermore, due to the rising incidence of various tumor cases, supportive government organizations such as IARC, CDC, and NIH, the research & development of new testing & screening methods is also projected to help promote market growth.
Asia Pacific on the other hand, is projected to witness the highest growth rate during the forecast years. This is attributed to the significant growth of the geriatric population exposed to risk factors in developing nations. Additionally, rise in initiatives by governments & private organizations to improve access to healthcare are also promoting market growth.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35B2174